Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally

Brain Research

Volumn 1088, Issue 1, 2006, Pages 83-92

  Wurtman, Richard J ^a   Ulus, Ismail H ^a,b   Cansev, Mehmet ^a,b   Watkins, Carol J ^a   Wang, Lei ^a   Marzloff, George ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; Docosahexaenoic acid; Neuronal membrane; Phosphatidylcholine; Synaptic protein; Uridine

Indexed keywords

BETA TUBULIN; BRAIN PROTEIN; CHOLINE; CYTOSKELETON PROTEIN; DOCOSAHEXAENOIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE; POSTSYNAPTIC DENSITY PROTEIN 95; PURINE P2Y RECEPTOR; SYNAPSIN I; URIDINE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; DOSE RESPONSE; DRUG EFFECT; GERBIL; MALE; NEURITE; NONHUMAN; PRIORITY JOURNAL; PYRIMIDINE METABOLISM; SYNAPTIC MEMBRANE;

ADMINISTRATION, ORAL; ANIMALS; BRAIN; CHOLINE; DIET; DOCOSAHEXAENOIC ACIDS; GENE EXPRESSION; GERBILLINAE; MALE; NERVE TISSUE PROTEINS; PHOSPHOLIPIDS; SYNAPSES; SYNAPSINS; TIME FACTORS; URIDINE;

ANIMALIA; GERBILLINAE;

EID: 33646592555     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.03.019     Document Type: Article

References (43)

1. Araki W., and Wurtman R.J. Control of membrane phosphatidylcholine biosynthesis by diacylglycerol levels in neuronal cells undergoing neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11946-11950
2. Babb S.M., Ke Y., Lange N., Kaufman M.J., Renshaw P.F., and Cohen B.M. Oral choline increases choline metabolites in human brain. Psychiatry Res. 130 (2004) 1-9
3. Cansev M., and Wurtman R.J. Exogenous cytidine-5′-diphosphocholine increases brain cytidine-5′-diphosphocholine levels in gerbils. 20th Biennial Meeting of the ISN-ESN Abstracts, 21-26 August 2005, Innsbruck, Austria. J. Neurochem. 94 Supp. 2 (2005) 105-106
4. Cansev M., Watkins C.J., van der Beek E.M., and Wurtman R.J. Oral uridine 5′ monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Res. 1058 (2005) 101-108
5. Cohen E.L., and Wurtman R.J. Brain acetylcholine: control by dietary choline. Science 191 (1976) 561-562
6. Coleman P., Federoff H., and Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63 (2004) 1155-1162
7. Cornford E.M., Braun L.D., and Oldendorf W.H. Carrier mediated blood-brain barrier transport of choline and certain choline analogs. J. Neurochem. 30 (1978) 299-308
8. Ferreira A., and Rapoport M. The synapsins: beyond the regulation of neurotransmitter release. Cell. Mol. Life Sci. 59 (2002) 589-595
9. Folch J., Lees M., and Sloane-Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol Chem. 226 (1957) 497-509
10. Fujita A., and Kurachi Y. SAP family proteins. Biochem. Biophys. Res. Commun. 269 (2000) 1-6
11. Genchev D.D., and Mandel P. CTP synthetase activity in neonatal and adult rat brain. J. Neurochem. 22 (1974) 1027-1030
12. Harris W.S. Omega-3 fatty acids. In: Coates P.M., Blackman M.R., Cragg G.M., Levine M., Moss J., and White J.D. (Eds). Encyclopedia of Dietary Supplements (2005), Marcel Dekker, New York 493-504
13. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., Ishibashi Y., Oka J.-I., and Shido O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J. Neurochem. 81 (2002) 1084-1091
14. Kennedy E.M., and Weiss S.B. The function of cytidine coenzymes in the biosynthesis of phospholipids. J. Biol. Chem. 222 (1956) 193-214
15. Knapp S., and Wurtman R.J. Enhancement of free fatty acid incorporation into phospholipids by choline plus cytidine. Brain Res. 822 (1999) 52-59
16. Labarca C., and Paigen K. A simple, rapid and sensitive DNA assay procedure. Anal. Biochem. 102 (1980) 344-352
17. Lee V., Trojanowsky J.Q., and Schlaepfer W.W. Induction of neurofilament triplet proteins in PC12 cells by nerve growth factor. Brain Res. 238 (1982) 169-180
18. + nucleoside cotransporter CNT2. J. Cereb. Blood Flow Metab. 21 (2001) 929-936
19. Lopez-Coviella I., Agut J., Savci V., Ortiz J.A., and Wurtman R.J. Evidence that 5′-Cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levels. J. Neurochem. 65 (1995) 889-894
20. Marszalek J.R., and Lodish H.F. Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. Annu. Rev. Cell Dev. Biol. 21 (2005) 633-657
21. Marszalek J.R., Kitidis C., DiRusso C.C., and Lodish H.F. Long-chain acyl-Coa synthetase 6 preferentially promotes DHA metabolism. J. Biol. Chem. 280 (2005) 10817-10826
22. McCann J.C., and Ames B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 82 (2005) 281-295
23. Millington W.R., and Wurtman R.J. Choline administration elevates brain phosphorylcholine concentrations. J. Neurochem. 38 (1982) 1748-1752
24. Nitsch R.M., Blusztajn J.K., Pittas A.G., Slack B.E., Growdon J.H., and Wurtman R.J. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 1671-1675
25. Pooler A.M., Guez D.H., Benedictus R., and Wurtman R.J. Uridine enhances neurite outgrowth in nerve growth factor-differentiated pheochromocytoma cells. Neuroscience 134 (2005) 207-214
26. Rapoport S.I. In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling. J. Mol. Neurosci. 16 (2001) 243-261
27. Richardson U.I., Watkins C.J., Pierre C., Ulus I.H., and Wurtman R.J. Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells. Brain Res. 971 (2003) 161-167
28. Ross B.M., Moszczynska A., Blusztajn J.K., Sherwin A., Lozano A., and Kish S.J. Phospholipid biosynthetic enzymes in human brain. Lipids 32 (1997) 351-358
29. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
30. Soderberg M., Edlund C., Kristensson K., and Dallner G. Fatty acid composition of brain phosholipids in aging and in Alzheimer's disease. Lipids 26 (1991) 421-425
31. Spanner S., and Ansell G.B. Choline kinase and ethanolamine kinase activity in the cytosol of nerve endings from rat forebrain. Biochem. J. 110 (1979) 201-206
32. Spector A.A. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J. Mol. Neurosci. 16 (2001) 159-165
33. Stalenhoef A.F.H., DeGraaf J., Wittekoek M.E., Bredie S.J.H., Demacker P.N.M., and Kastelein J.J.P. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia. Atherosclerosis 153 (2000) 129-138
34. Suzuki N.N., Koizumi K., Fukushima M., Matsuda A., and Inagaki F. Structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase. Structure 12 (2004) 751-764
35. Svanborg A., and Svennerholm L. Plasma total lipids, cholesterol, triglycerides, phospholipids and free fatty acids in a healthy Scandinavian population. Acta Med. Scand. 169 (1961) 43-49
36. Teather L.A., and Wurtman R.J. Dietary cytidine (5′)-diphosphocholine supplementation protects against development of memory deficits in aging rats. Prog. Neuro-psychopharmacol. Biol. Psychiatry 27 (2003) 711-717
37. Teather L.A., and Wurtman R.J. Dietary CDP-choline supplementation prevents memory impairment caused by impoverished environmental conditions in rats. Learn. Mem. 12 (2005) 39-43
38. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991) 572-580
39. Ulus I.H., Wurtman R.J., Mauron C., and Blusztajn J.K. Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes. Brain Res. 484 (1989) 217-227
40. Wang L., Pooler A.M., Regan M.A., and Wurtman R.J. Uridine increases neurotransmitter release in aged rats. 34th Society for Neuroscience Abstracts, 23-27 October, San Diego, CA, USA (2004)
41. Wang L., Pooler A.M., Regan M.A., and Wurtman R.J. Dietary uridine-5′-monophosphate supplementation increases potassium-induced dopamine release and promotes neurite outgrowth in aged rats. J. Mol. Neurosci. 27 (2005) 137-146
42. Wurtman R.J., Regan M., Ulus I., and Yu L. Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem. Pharmacol. 60 (2000) 989-992
43. Yu V. Scientific rationale and benefits of nucleotide supplementation of infant formula. J. Pediatr. Child Health 38 (2002) 543-549